Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-4101
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity ; volume:12 ; number:1 ; day:6 ; month:11 ; year:2021 ; pages:1-8 ; date:12.2021
Insights into imaging ; 12, Heft 1 (6.11.2021), 1-8, 12.2021
- Creator
-
Monti, Caterina Beatrice
Schiaffino, Simone
Galimberti Ortiz, Maria Del Mar
Capra, Davide
Zanardo, Moreno
Benedictis, Elena De
Luporini, Alberto Gianluigi
Spagnolo, Pietro
Secchi, Francesco
Sardanelli, Francesco
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13244-021-01069-4
- URN
-
urn:nbn:de:101:1-2022012019085044093801
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Monti, Caterina Beatrice
- Schiaffino, Simone
- Galimberti Ortiz, Maria Del Mar
- Capra, Davide
- Zanardo, Moreno
- Benedictis, Elena De
- Luporini, Alberto Gianluigi
- Spagnolo, Pietro
- Secchi, Francesco
- Sardanelli, Francesco
- SpringerLink (Online service)
Other Objects (12)
Anthracycline Chemotherapy and Cardiotoxicity
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18F-FDG PET/CT as a new biomarker
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging
Anthracycline Chemotherapy and Cardiotoxicity
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18F-FDG PET/CT as a new biomarker
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging
Anthracycline Chemotherapy and Cardiotoxicity
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18F-FDG PET/CT as a new biomarker